insights_auto
Why is SABS up 2,31%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
3,10 USD
arrow_upward
+2,31%(+0,070) 1D
3,09 USD
arrow_downward
-0,33% (-0,010)bedtimeAfter hours
Closed: 9-ноя., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
3,10 USD
High
3,18 USD
Low
3,05 USD
Mkt. cap
282,06 млн
Avg. vol.
642,58 миң
Volume
0,00
52-wk high
5,15 USD
52-wk low
2,44 USD
EPS
-0,63 USD
Beta
0,67
Shares outstanding
90,09 млн
No. of employees
86
Open
3,10 USD
High
3,18 USD
Low
3,05 USD
Mkt. cap
282,06 млн
Avg. vol.
642,58 миң
Volume
0,00
52-wk high
5,15 USD
52-wk low
2,44 USD
EPS
-0,63 USD
Beta
0,67
Shares outstanding
90,09 млн
No. of employees
86
News stories
From web sources and news partners
Morningstar
·
24 мүнөт мурун
VisionWave (Nasdaq: VWAV) Adds Six Field-Tested, Commercially Available Unmanned Aerial Systems to Its STRATUM Aerial Portfolio
Yahoo Finance
·
18 мүнөт мурун
Direxion Daily S&P 500 Bull 3X (SPXL) Adds Apple and Nvidia on Friday
Seeking Alpha
·
13 мүнөт мурун
Sell The Bounce, AI Bubble Burst To Resume (NASDAQ:QQQ)
The Motley Fool
·
31 мүнөт мурун
This Vanguard ETF Has Outperformed the S&P 500 and Nasdaq Composite
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
HeadquartersМайами Бич, Флорида, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Websitesab.bio